Bertoldo F - Search Results

1

The prevention of corticosteroid-induced osteoporosis with nandrolone decanoate.

Adami S, Fossaluzza V, Rossini M, Bertoldo F, Gatti D, Zamberlan N, Lo Cascio V. Adami S, et al. Among authors: bertoldo f. Bone Miner. 1991 Oct;15(1):73-81. doi: 10.1016/0169-6009(91)90111-c. Bone Miner. 1991. PMID: 1747568 Clinical Trial.

2

The effects of menopause and estrogen replacement therapy on the renal handling of calcium.

Adami S, Gatti D, Bertoldo F, Rossini M, Fratta-Pasini A, Zamberlan N, Facci E, Lo Cascio V. Adami S, et al. Among authors: bertoldo f. Osteoporos Int. 1992 Jul;2(4):180-5. doi: 10.1007/BF01623924. Osteoporos Int. 1992. PMID: 1611223

3

Regulation of calcium-parathyroid hormone feedback in primary hyperparathyroidism: effects of bisphosphonate treatment.

Adami S, Mian M, Bertoldo F, Rossini M, Jayawerra P, O'Riordan JL, Lo Cascio V. Adami S, et al. Among authors: bertoldo f. Clin Endocrinol (Oxf). 1990 Sep;33(3):391-7. doi: 10.1111/j.1365-2265.1990.tb00504.x. Clin Endocrinol (Oxf). 1990. PMID: 2147599 Clinical Trial.

4

Transdermal estradiol in the treatment of postmenopausal bone loss.

Adami S, Suppi R, Bertoldo F, Rossini M, Residori M, Maresca V, Lo Cascio V. Adami S, et al. Among authors: bertoldo f. Bone Miner. 1989 Aug;7(1):79-86. doi: 10.1016/0169-6009(89)90064-0. Bone Miner. 1989. PMID: 2670019 Clinical Trial.

5

The use of dichloromethylene bisphosphonate and aminobutane bisphosphonate in hypercalcemia of malignancy.

Adami S, Bolzicco GP, Rizzo A, Salvagno G, Bertoldo F, Rossini M, Suppi R, Lo Cascio V. Adami S, et al. Among authors: bertoldo f. Bone Miner. 1987 Aug;2(5):395-404. Bone Miner. 1987. PMID: 2975514

6

Bone mineral metabolism in girls with precocious puberty during gonadotrophin-releasing hormone agonist treatment.

Antoniazzi F, Bertoldo F, Zamboni G, Valentini R, Sirpresi S, Cavallo L, Adami S, Tatò L. Antoniazzi F, et al. Among authors: bertoldo f. Eur J Endocrinol. 1995 Oct;133(4):412-7. doi: 10.1530/eje.0.1330412. Eur J Endocrinol. 1995. PMID: 7581963

7

Acute effects of deflazacort and prednisone on rates of mineralization and bone formation.

Lo Cascio V, Kanis JA, Beneton MN, Bertoldo F, Adami S, Poggi G, Zanolin ME. Lo Cascio V, et al. Among authors: bertoldo f. Calcif Tissue Int. 1995 Feb;56(2):109-12. doi: 10.1007/BF00296340. Calcif Tissue Int. 1995. PMID: 7736317 Clinical Trial.

8

Effects of two oral doses of alendronate in the treatment of Paget's disease of bone.

Adami S, Mian M, Gatti P, Rossini M, Zamberlan N, Bertoldo F, Lo Cascio V. Adami S, et al. Among authors: bertoldo f. Bone. 1994 Jul-Aug;15(4):415-7. doi: 10.1016/8756-3282(94)90818-4. Bone. 1994. PMID: 7917580 Clinical Trial.

9

Effect of bisphosphonate therapy and parathyroidectomy on the urinary excretion of galactosylhydroxylysine in primary hyperparathyroidism.

LoCascio V, Braga V, Bertoldo F, Bettica P, Pasini AF, Stefani L, Moro L. LoCascio V, et al. Among authors: bertoldo f. Clin Endocrinol (Oxf). 1994 Jul;41(1):47-51. doi: 10.1111/j.1365-2265.1994.tb03783.x. Clin Endocrinol (Oxf). 1994. PMID: 8050131

10

Duration of the effects of intravenous alendronate in postmenopausal women and in patients with primary hyperparathyroidism and Paget's disease of bone.

Adami S, Zamberlan N, Mian M, Dorizzi R, Rossini M, Braga B, Gatti D, Bertoldo F, Locascio V. Adami S, et al. Among authors: bertoldo f. Bone Miner. 1994 May;25(2):75-82. doi: 10.1016/s0169-6009(08)80249-8. Bone Miner. 1994. PMID: 8086853

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My Custom Filters

Publication date

Text availability

Article attribute

Article type

Article Language

Species

Sex

Age

Other

159 results

Search Page

Filters